MOPA — Medical Oncology Prior Authorization
0.1.1-snapshot-080926 - snapshot-080926 United States of America flag

MOPA — Medical Oncology Prior Authorization - Local Development build (v0.1.1-snapshot-080926) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

PlanDefinition: Example Regimen Definition: TH (Paclitaxel + Trastuzumab, Weekly) (Experimental)

Official URL: http://hl7.org/fhir/us/codex-mopa/PlanDefinition/RegimenTH Version: 0.1.1-snapshot-080926
Standards status: Informative Computable Name: RegimenTH

Weekly Paclitaxel + Trastuzumab for 12 weeks for HER2+ early breast cancer.

Metadata
Title TH: Paclitaxel + Trastuzumab (Weekly) — HER2+ Breast Cancer
Version 0.1.1-snapshot-080926
Experimental true
Subject Type Malignant neoplasm of breast
Jurisdiction United States of America
Steward (Publisher) HL7 International / Clinical Interoperability Council
Steward Contact HL7 International / Clinical Interoperability Council
Description

Weekly Paclitaxel + Trastuzumab for 12 weeks for HER2+ early breast cancer.
Type Order Set
PlanDefinition Action
Id paclitaxel-th
Title Paclitaxel 80 mg/m² IV — Day 1 of each 7-day cycle
Description Paclitaxel 80 mg/m² IV over 1 hour, weekly (day 1 of 7-day cycle) x12 doses
Timing Count 12 times, Once per 7 days
PlanDefinition Action
Id trastuzumab-th
Title Trastuzumab 4 mg/kg (loading) then 2 mg/kg IV weekly
Description Trastuzumab 4 mg/kg IV loading dose week 1, then 2 mg/kg IV weekly (day 1 of 7-day cycle) x11 doses
Timing Count 12 times, Once per 7 days
Generated using version 0.5.4 of the sample-content-ig Liquid templates